Herborium Group Stock Current Valuation
Valuation analysis of Herborium Group helps investors to measure Herborium's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Herborium Group Company Current Valuation Analysis
Herborium's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Herborium Current Valuation | 220.29 K |
Most of Herborium's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Herborium Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Herborium Group has a Current Valuation of 220.29 K. This is 100.0% lower than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Herborium Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Herborium's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Herborium could also be used in its relative valuation, which is a method of valuing Herborium by comparing valuation metrics of similar companies.Herborium is currently under evaluation in current valuation category among its peers.
Herborium Fundamentals
Profit Margin | 0.26 % | ||||
Operating Margin | (0.98) % | ||||
Current Valuation | 220.29 K | ||||
Shares Outstanding | 2.2 B | ||||
Price To Sales | 2.55 X | ||||
Revenue | 908.6 K | ||||
Gross Profit | 125.4 K | ||||
EBITDA | (250.2 K) | ||||
Net Income | (32.2 K) | ||||
Cash And Equivalents | 120.1 K | ||||
Cash Per Share | 0.20 X | ||||
Total Debt | 290 K | ||||
Book Value Per Share | (2.03) X | ||||
Cash Flow From Operations | 29.6 K | ||||
Earnings Per Share | 0.12 X | ||||
Beta | 89.84 | ||||
Market Capitalization | 220.29 K | ||||
Total Asset | 187.6 K | ||||
Retained Earnings | (4.93 M) | ||||
Working Capital | (112 K) | ||||
Current Asset | 63 K | ||||
Current Liabilities | 175 K | ||||
Z Score | -35.7 | ||||
Annual Yield | 0.02 % | ||||
Net Asset | 187.6 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Herborium Pink Sheet
If you are still planning to invest in Herborium Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Herborium's history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |